Alteon's Investigational Drug Alagebrium Demonstrates Ability To Improve Functional Membrane Transport In A Rat Model Of Chronic Peritoneal Dialysis

... Alteon Inc. (Amex: ALT) announced today that a preclinical study presented at the 27th Annual Dialysis Conference in Denver, February 18-20, 2007 (http://www.muhealth.org/~dialysis) demonstrates the beneficial effects of Alteon's drug alagebrium, an A.G.E. crosslink breaker, in a rat model of peritoneal dialysis. Conducted by Jeong-Ho Lee, M.D. [click link for full article] ...